These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 15215173)
1. Amplification and overexpression of SKP2 are associated with metastasis of non-small-cell lung cancers to lymph nodes. Yokoi S; Yasui K; Mori M; Iizasa T; Fujisawa T; Inazawa J Am J Pathol; 2004 Jul; 165(1):175-80. PubMed ID: 15215173 [TBL] [Abstract][Full Text] [Related]
2. A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers. Yokoi S; Yasui K; Saito-Ohara F; Koshikawa K; Iizasa T; Fujisawa T; Terasaki T; Horii A; Takahashi T; Hirohashi S; Inazawa J Am J Pathol; 2002 Jul; 161(1):207-16. PubMed ID: 12107105 [TBL] [Abstract][Full Text] [Related]
3. Suppression of anoikis by SKP2 amplification and overexpression promotes metastasis of esophageal squamous cell carcinoma. Wang XC; Wu YP; Ye B; Lin DC; Feng YB; Zhang ZQ; Xu X; Han YL; Cai Y; Dong JT; Zhan QM; Wu M; Wang MR Mol Cancer Res; 2009 Jan; 7(1):12-22. PubMed ID: 19147533 [TBL] [Abstract][Full Text] [Related]
4. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer. Osoegawa A; Yoshino I; Tanaka S; Sugio K; Kameyama T; Yamaguchi M; Maehara Y J Clin Oncol; 2004 Oct; 22(20):4165-73. PubMed ID: 15483027 [TBL] [Abstract][Full Text] [Related]
6. Skp2 regulates non-small cell lung cancer cell growth by Meg3 and miR-3163. Su L; Han D; Wu J; Huo X Tumour Biol; 2016 Mar; 37(3):3925-31. PubMed ID: 26482610 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer. Chiappetta G; De Marco C; Quintiero A; Califano D; Gherardi S; Malanga D; Scrima M; Montero-Conde C; Cito L; Monaco M; Motti ML; Pasquinelli R; Agosti V; Robledo M; Fusco A; Viglietto G Endocr Relat Cancer; 2007 Jun; 14(2):405-20. PubMed ID: 17639054 [TBL] [Abstract][Full Text] [Related]
8. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer. Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409 [TBL] [Abstract][Full Text] [Related]
9. SIRT2 inhibits non-small cell lung cancer cell growth through impairing Skp2-mediated p27 degradation. Li Z; Huang J; Yuan H; Chen Z; Luo Q; Lu S Oncotarget; 2016 Apr; 7(14):18927-39. PubMed ID: 26942878 [TBL] [Abstract][Full Text] [Related]
10. TERC identified as a probable target within the 3q26 amplicon that is detected frequently in non-small cell lung cancers. Yokoi S; Yasui K; Iizasa T; Imoto I; Fujisawa T; Inazawa J Clin Cancer Res; 2003 Oct; 9(13):4705-13. PubMed ID: 14581340 [TBL] [Abstract][Full Text] [Related]
11. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis. Masuda TA; Inoue H; Sonoda H; Mine S; Yoshikawa Y; Nakayama K; Nakayama K; Mori M Cancer Res; 2002 Jul; 62(13):3819-25. PubMed ID: 12097295 [TBL] [Abstract][Full Text] [Related]
12. CKS1B overexpression implicates clinical aggressiveness of hepatocellular carcinomas but not p27(Kip1) protein turnover: an independent prognosticator with potential p27 (Kip1)-independent oncogenic attributes? Huang CW; Lin CY; Huang HY; Liu HW; Chen YJ; Shih DF; Chen HY; Juan CC; Ker CG; Huang CY; Li CF; Shiue YL Ann Surg Oncol; 2010 Mar; 17(3):907-22. PubMed ID: 19866239 [TBL] [Abstract][Full Text] [Related]
13. The prognostic value of overexpression of Skp2 mRNA in non-small cell lung cancer. Takanami I Oncol Rep; 2005 Apr; 13(4):727-31. PubMed ID: 15756449 [TBL] [Abstract][Full Text] [Related]
14. Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas. Huang HY; Kang HY; Li CF; Eng HL; Chou SC; Lin CN; Hsiung CY Clin Cancer Res; 2006 Jan; 12(2):487-98. PubMed ID: 16428491 [TBL] [Abstract][Full Text] [Related]
15. [Expression of SKP2 protein in lung carcinoma and its implication for prognosis]. Zhao J; Yang CL; Zhao SY Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):289-92. PubMed ID: 17760257 [TBL] [Abstract][Full Text] [Related]
16. E2F-1, Skp2 and cyclin E oncoproteins are upregulated and directly correlated in high-grade neuroendocrine lung tumors. Salon C; Merdzhanova G; Brambilla C; Brambilla E; Gazzeri S; Eymin B Oncogene; 2007 Oct; 26(48):6927-36. PubMed ID: 17471231 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results. Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205 [TBL] [Abstract][Full Text] [Related]
18. Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells. Hung WC; Tseng WL; Shiea J; Chang HC Cancer Lett; 2010 Feb; 288(2):156-61. PubMed ID: 19625121 [TBL] [Abstract][Full Text] [Related]
19. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas. An immunohistochemical and fluorescence in situ hybridization study. Suzuki S; Dobashi Y; Sakurai H; Nishikawa K; Hanawa M; Ooi A Cancer; 2005 Mar; 103(6):1265-73. PubMed ID: 15712203 [TBL] [Abstract][Full Text] [Related]
20. Skp2 gene copy number aberrations are common in non-small cell lung carcinoma, and its overexpression in tumors with ras mutation is a poor prognostic marker. Zhu CQ; Blackhall FH; Pintilie M; Iyengar P; Liu N; Ho J; Chomiak T; Lau D; Winton T; Shepherd FA; Tsao MS Clin Cancer Res; 2004 Mar; 10(6):1984-91. PubMed ID: 15041716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]